Abbott Norvir Returns To Market Via Contract Manufacturer
Executive Summary
Abbott's HIV protease inhibitor Norvir capsules will be available the week of July 5 as a soft gelatin reformulation outsourced to a contract manufacturer.
You may also be interested in...
Abbott Diagnostics Manufacturing Issues Could Decrease Alza Merger Value
Abbott's pending merger with Alza could give FDA leverage in discussions over quality control problems in Abbott's diagnostics business.
Abbott Diagnostics Manufacturing Issues Could Decrease Alza Merger Value
Abbott's pending merger with Alza could give FDA leverage in discussions over quality control problems in Abbott's diagnostics business.
Abbott Expects Prevacid Growth Of 25% Despite Looming PPI Competition
Abbott is expecting 25% U.S. growth for TAP's Prevacid next year, despite potential competition from two new proton pump inhibitors.